STOCK TITAN

Bausch Health Companies (NYSE: BHC) CAO reports 3,125-share tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bausch Health Companies Inc. senior vice president, controller and chief accounting officer Steven Hyosig Lee reported a tax-withholding disposition of 3,125 common shares on July 14, 2026, at $4.75 per share, withheld by the issuer to satisfy tax obligations on vesting of Restricted Share Units. Following this, he directly holds 70,114 common shares.

Positive

  • None.

Negative

  • None.
Insider LEE STEVEN HYOSIG
Role SVP, Controller & CAO
Type Security Shares Price Value
Tax Withholding Common Shares, No Par Value 3,125 $4.75 $15K
Holdings After Transaction: Common Shares, No Par Value — 70,114 shares (Direct)
Footnotes (1)
  1. [object Object]
Tax-withheld shares 3,125 shares Common shares withheld to satisfy tax obligations on RSU vesting
Withholding price $4.75 per share Value per share for tax-withholding disposition on July 14, 2026
Shares held after transaction 70,114 shares Direct common share holdings of Steven Hyosig Lee following tax withholding
Restricted Share Units financial
"due upon vesting of Restricted Share Units."
Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.
tax withholding obligations financial
"withheld to satisfy the tax withholding obligations due upon vesting"
Common Shares, No Par Value financial
"security titled Common Shares, No Par Value of the Issuer"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Bausch Health (BHC) executive Steven Hyosig Lee report?

Steven Hyosig Lee reported a tax-withholding disposition of Bausch Health common shares. 3,125 shares were withheld by the issuer to satisfy tax obligations arising from the vesting of his Restricted Share Units, as reflected in the Form 4 filing.

How many Bausch Health (BHC) shares were withheld for Steven Hyosig Lee’s taxes and at what price?

The transaction shows 3,125 common shares of Bausch Health withheld at $4.75 per share. These shares were retained by the issuer specifically to cover Lee’s tax withholding obligations associated with the vesting of Restricted Share Units.

How many Bausch Health (BHC) shares does Steven Hyosig Lee hold after this Form 4 transaction?

After the reported tax-withholding disposition, Steven Hyosig Lee directly holds 70,114 Bausch Health common shares. This figure represents his post-transaction direct ownership as disclosed in the Form 4 for the July 14, 2026 transaction.

What position does Steven Hyosig Lee hold at Bausch Health (BHC)?

Steven Hyosig Lee serves as Bausch Health’s senior vice president, controller and chief accounting officer. His role is identified in the insider ownership disclosure, indicating he is an officer but not a director or 10% beneficial owner.

What does the tax-withholding code on Steven Hyosig Lee’s Bausch Health (BHC) Form 4 mean?

The Form 4 uses transaction code F, described as payment of exercise price or tax liability by delivering securities. In this case, common shares were withheld by Bausch Health to satisfy Lee’s tax withholding obligations on vesting Restricted Share Units.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LEE STEVEN HYOSIG

(Last)(First)(Middle)
400 SOMERSET CORPORATE BLVD.

(Street)
BRIDGEWATER NEW JERSEY 08807

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Controller & CAO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares, No Par Value07/14/2026F3,125(1)D$4.7570,114D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
/s/ Brianna M. Dorsi, attorney-in-fact07/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)